Related Experiment Video
Updated: Jun 7, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Immunonutrition in patients undergoing major upper gastrointestinal surgery: a prospective double-blind randomised
M H Sodergren1, P Jethwa, S Kumar
1Department of Biosurgery and Surgical Technology, Imperial College, St. mary's Hospital, London, United Kingdom. m.sodergren@imperial.ac.uk
This study found no significant benefits of immunonutrition in major upper GI surgery patients. Further research on homogeneous groups is needed to confirm its role in surgical recovery.
Area of Science:
- Surgical Nutrition
- Gastrointestinal Surgery
- Immunonutrition
Background:
- Immunonutrition may reduce inflammation and hospital stay in surgical patients.
- Previous studies used heterogeneous patient groups and varied immunonutrition formulas.
- The specific impact of a defined immunonutrition formula in major upper GI surgery requires investigation.
Purpose of the Study:
- To assess the effect of a specific immunonutrition formula on inflammatory and immune responses in patients undergoing major upper GI surgery.
- To compare clinical outcomes, including length of hospital stay and adverse events, between patients receiving immunonutrition and conventional feeding.
- To evaluate changes in key nutritional and inflammatory markers.
Main Methods:
- Prospective, double-blind, randomized controlled study comparing an immunonutrition feed to a control feed.
- Participants: Patients undergoing major upper gastrointestinal surgery.
- Primary endpoints: C-reactive protein (CRP), prealbumin, and retinol-binding protein (RBP) levels; Secondary endpoints: clinical outcomes and nutritional markers.
Main Results:
- No statistically significant differences in primary inflammatory or nutritional markers between groups.
- No difference in length of hospital stay or other clinical outcomes observed.
- Vitamin C levels were significantly higher in the immunonutrition group; both feeds were well-tolerated.
Conclusions:
- The studied immunonutrition formula did not demonstrate significant benefits in inflammatory markers, nutritional status, or clinical outcomes in major upper GI surgery.
- Potential reasons for negative findings include insufficient study power or patient heterogeneity.
- Further multi-center trials with homogeneous patient groups are recommended to clarify the role of immunonutrition in this surgical population.
Related Concept Videos
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Enteral Nutrition I: Orogastric and Nasogastric Feeding
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: